AbbVie Inc. is 365.0x more valuable than Wave Life Sciences Ltd. by market capitalization ($397.44 B vs $1.09 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | WVE | ABBV |
|---|---|---|
| Market cap | $1.09 B | $397.44 B |
| US-listed rank | #2576 | #28 |
| Revenue (latest FY) | $42.73M | $61.16B |
| Net income (latest FY) | -$204.38M | $4.23B |
| Net margin | -478.3% | 6.9% |
| P/E (trailing FY) | - | 94.0 |
| SEC filings | 695 | 1,008 |
AbbVie Inc. is 365.0x more valuable than Wave Life Sciences Ltd. by market capitalization ($397.44 B vs $1.09 B).
In their latest fiscal years, Wave Life Sciences Ltd. reported $42.73M in revenue while AbbVie Inc. reported $61.16B.
Full pages: Wave Life Sciences Ltd. and AbbVie Inc., or browse the full rankings.